FIELD: cardiology. SUBSTANCE: new cardiac drug consists of thymogen administered intravenously in dose 1 to 20 mcg/kg. Application of drug in experiment and clinic in patients suffering myocardial infarction and angina pectoris allowed patients' state to be relieved with no adverse effects. EFFECT: facilitated treatment. 6 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 1-(2,4,6-TRIMETHYLPHENYL)-2-[(2'-HYDROXY-3'-PHENYLOXY)-N-SUBSTITUTED-AMINOMETHYL]-PYRROLES AND THEIR SALTS ELICITING ANTI-ARRHYTHMIC AND ANTI-ISCHEMIC ACTIVITY | 2002 |
|
RU2231525C1 |
| ANTIHYPOXIC AGENT | 2001 |
|
RU2213571C2 |
| METHOD OF TREATING PATIENTS WITH ISCHEMIC HEART DISEASE | 2010 |
|
RU2428978C1 |
| METHOD TO TREAT ISCHEMIC CARDIAC DISEASE | 1995 |
|
RU2089168C1 |
| METHOD FOR DETERMINATION OF INDIVIDUAL SENSITIVITY TO BETA-ADRENOBLOCKER IN PATIENTS WITH ISCHEMIC HEART DISEASE | 0 |
|
SU1635962A1 |
| PYRROLO[1,2-A]PYRAZINES OR THEIR FUMARATES SHOWING ANTIARRHYTHMIC AND ANTI-ISCHEMIC ACTIVITY | 2000 |
|
RU2194707C2 |
| METHOD FOR TREATING THE CASES OF MYOCARDIAL ISCHEMIA | 2001 |
|
RU2207888C2 |
| METHOD FOR TREATING MYOCARDIAL INFARCTION | 1990 |
|
RU2032422C1 |
| METHOD FOR FORECASTING THE DEVELOPMENT OF THE ACUTE FORM OF HEART ISCHEMIA | 0 |
|
SU1652913A1 |
| METHOD FOR TREATING CARDIAC ISCHEMIA DISEASE, STRESS ANGINA PECTORIS OF THE I-II FUNCTIONAL CLASSES | 1996 |
|
RU2147248C1 |
